The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for dexrazoxane (Maxx Pharma Pty Ltd)
Active ingredients
dexrazoxane
Sponsor
Date of review outcome
Lapse date
Type
Orphan Drug
Dosage form(s)
powder for solution for injection/infusion
Indication
For the treatment of anthracycline extravasation
Therapeutic area
Dermatology